Christine Gebski - Mar 2, 2023 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
SVP, Filtration & Chromatography
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Mar 2, 2023
Transactions value $
-$23,688
Form type
4
Date filed
3/6/2023, 04:28 PM
Previous filing
Feb 28, 2023
Next filing
May 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Award $0 +3.47K +11.88% $0.00 32.7K Mar 2, 2023 Direct F1
transaction RGEN Common Stock Award $0 +375 +1.15% $0.00 33K Mar 3, 2023 Direct F2
transaction RGEN Common Stock Tax liability -$23.7K -126 -0.38% $188.00 32.9K Mar 3, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Award $0 +3.59K $0.00 3.59K Mar 2, 2023 Common Stock 3.59K $180.48 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ms. Gebski was awarded 3,467 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
F2 Represents shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 1, 2022. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.
F3 Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs.
F4 One third of the stock options will vest and become exercisable annually on March 2, 2024, March 2, 2025, and March 2, 2026.

Remarks:

SVP, Filtration & Chromatography